Endometriosis Trial, Recruiting NCT06549985 Sponsor: Washington University School of Medicine Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06549985
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 48 years old
  • A surgeon has confirmed through an operation that you have endometriosis
  • You have had ongoing pelvic pain (pain felt in the pelvic area, not only during your period) that has lasted 6 months or longer
  • You are not planning to have any surgery before or during the study program
  • You are able to attend at least 6 out of 8 weekly sessions (each 2 hours long) held on the Washington University campus
  • You are comfortable reading and speaking English, as all group sessions and materials are in English

Who may not be able to join:

  • You are currently pregnant
  • You have a serious physical condition that would prevent you from participating in yoga
  • You have had surgery on your hip or spine in the past
  • You have a current or past diagnosis of a psychiatric condition that includes psychosis (confirm with trial site)
  • You have used opioid pain medications on 5 or more days in the past 3 months, unless it was within the 6 weeks following a surgery
  • Both of your ovaries have been surgically removed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Whitney Ross, MD, Washington University School of Medicine

Phone: 314-747-5470

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 March 2025
Est. completion
30 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Reported Outcomes Measurement Information System (PROMIS) pain interference Short Form (SF) 8a

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov